MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20227045

March 30, 2022

国药准字H20213280

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg,按C21H24FN3O4计)

化学药品

March 30, 2022

Company Information

Applicant Company

江西省抚州市东乡区东红大道516号

Manufacturing Company

江西省抚州市东乡区东红大道516号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath